National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Opdivo® is indicated for the treatment of locally advanced or metastatic squamous NSCLC after prior chemotherapy in adults.

Rapid Review

Commenced Completed Outcome
02/07/2015 16/07/2015 Full Pharmacoeconomic Evaluation Recommended

Pharmacoeconomic Evaluation

Commenced Completed Outcome
30/10/2015  10/03/2016 Reimbursement not Recommended at the Submitted Price.

Summary

 

The HSE has approved reimbursement following confidential price negotiations September 2018